Literature DB >> 24729673

The Role of Gastroesophageal Reflux and Microaspiration in Idiopathic Pulmonary Fibrosis.

Joyce S Lee1.   

Abstract

There has been controversy regarding the relationship between gastroesophageal reflux, microaspiration, and idiopathic pulmonary fibrosis (IPF). In the last decade, there is increasing evidence supporting a relationship between gastroesophageal reflux, microaspiration, and IPF. Specifically, gastroesophageal reflux is common in IPF, is often asymptomatic in this population, and may impact disease progression and the natural history of IPF. More intriguing are the data suggesting that treatment of gastroesophageal reflux, either medical or surgical, may slow disease progression, as measured by change in forced vital capacity, and improve survival in IPF. Despite the growing evidence, there are still many gaps in our understanding of this relationship. Some of the major gaps include the discrepancy between the prevalence of gastroesophageal reflux in the general population compared to the prevalence of IPF, the unclear causative agent leading to injury, the lack of reliable methods to evaluate for gastroesophageal reflux and microaspiration, and the role of treatment. Further research, including a randomized controlled trial of anti-reflux therapy, needs to be done to clarify the relationship between gastroesophageal reflux, microaspiration, and IPF.

Entities:  

Keywords:  gastroesophageal reflux; idiopathic pulmonary fibrosis; microaspiration; pathogenesis; treatment

Year:  2014        PMID: 24729673      PMCID: PMC3979481          DOI: 10.1097/cpm.0000000000000031

Source DB:  PubMed          Journal:  Clin Pulm Med


  40 in total

1.  Typical GERD symptoms and esophageal pH monitoring are not enough to diagnose pharyngeal reflux.

Authors:  Brant K Oelschlager; Lily Chang; Charles E Pope; Carlos A Pellegrini
Journal:  J Surg Res       Date:  2005-04-14       Impact factor: 2.192

2.  Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis.

Authors:  Joyce S Lee; Jay H Ryu; Brett M Elicker; Carmen P Lydell; Kirk D Jones; Paul J Wolters; Talmadge E King; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2011-06-23       Impact factor: 21.405

3.  Incidence and prevalence of idiopathic pulmonary fibrosis.

Authors:  Ganesh Raghu; Derek Weycker; John Edelsberg; Williamson Z Bradford; Gerry Oster
Journal:  Am J Respir Crit Care Med       Date:  2006-06-29       Impact factor: 21.405

Review 4.  Update in the diagnosis of gastroesophageal reflux disease.

Authors:  Radu Tutuian
Journal:  J Gastrointestin Liver Dis       Date:  2006-09       Impact factor: 2.008

5.  Diffuse pulmonary fibrosis and hiatus hernia.

Authors:  J E Pearson; R S Wilson
Journal:  Thorax       Date:  1971-05       Impact factor: 9.139

6.  Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  J S Lee; J W Song; P J Wolters; B M Elicker; T E King; D S Kim; H R Collard
Journal:  Eur Respir J       Date:  2011-12-19       Impact factor: 16.671

7.  Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease.

Authors:  Colas Tcherakian; Vincent Cottin; Pierre-Yves Brillet; Olivia Freynet; Nicolas Naggara; Zohra Carton; Jean-François Cordier; Michel Brauner; Dominique Valeyre; Hilario Nunes
Journal:  Thorax       Date:  2010-09-29       Impact factor: 9.139

8.  Idiopathic pulmonary fibrosis: how often is it really idiopathic?

Authors:  Marco G Patti; Pietro Tedesco; Jeffrey Golden; Steven Hays; Charles Hoopes; Adam Meneghetti; Tanuja Damani; Lawrence W Way
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

9.  Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis.

Authors:  R W Tobin; C E Pope; C A Pellegrini; M J Emond; J Sillery; G Raghu
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

10.  Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients.

Authors:  Edoardo Savarino; Roberto Carbone; Elisa Marabotto; Manuele Furnari; Luca Sconfienza; Massimo Ghio; Patrizia Zentilin; Vincenzo Savarino
Journal:  Eur Respir J       Date:  2013-03-07       Impact factor: 16.671

View more
  11 in total

Review 1.  Asbestosis and environmental causes of usual interstitial pneumonia.

Authors:  Mridu Gulati; Carrie A Redlich
Journal:  Curr Opin Pulm Med       Date:  2015-03       Impact factor: 3.155

2.  Occupational risk factors for idiopathic pulmonary fibrosis in Southern Europe: a case-control study.

Authors:  Giulia Paolocci; Ilenia Folletti; Kjell Torén; Magnus Ekström; Marco Dell'Omo; Giacomo Muzi; Nicola Murgia
Journal:  BMC Pulm Med       Date:  2018-05-21       Impact factor: 3.317

3.  Reflux aspiration in lungs of dogs with respiratory disease and in healthy West Highland White Terriers.

Authors:  O L Merita Määttä; Henna P Laurila; Saila Holopainen; Liisa Lilja-Maula; Marika Melamies; Sanna J Viitanen; L R Johnson; Ninna Koho; Mikko Neuvonen; Mikko Niemi; Minna M Rajamäki
Journal:  J Vet Intern Med       Date:  2018-10-12       Impact factor: 3.333

4.  Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials.

Authors:  Ulrich Costabel; Jürgen Behr; Bruno Crestani; Wibke Stansen; Rozsa Schlenker-Herceg; Susanne Stowasser; Ganesh Raghu
Journal:  Respir Res       Date:  2018-09-03

Review 5.  Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis.

Authors:  Sang Hoon Lee; Yoomi Yeo; Tae Hyung Kim; Hong Lyeol Lee; Jin Hwa Lee; Yong Bum Park; Jong Sun Park; Yee Hyung Kim; Jin Woo Song; Byung Woo Jhun; Hyun Jung Kim; Jinkyeong Park; Soo Taek Uh; Young Whan Kim; Dong Soon Kim; Moo Suk Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-02-28

6.  Idiopathic pulmonary fibrosis and GERD: links and risks.

Authors:  Matteo Ghisa; Carla Marinelli; Vincenzo Savarino; Edoardo Savarino
Journal:  Ther Clin Risk Manag       Date:  2019-09-05       Impact factor: 2.423

Review 7.  Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management.

Authors:  Johan van Cleemput; Andrea Sonaglioni; Wim A Wuyts; Monica Bengus; John L Stauffer; Sergio Harari
Journal:  Adv Ther       Date:  2018-12-15       Impact factor: 3.845

Review 8.  Update on diagnosis and treatment of idiopathic pulmonary fibrosis.

Authors:  José Baddini-Martinez; Bruno Guedes Baldi; Cláudia Henrique da Costa; Sérgio Jezler; Mariana Silva Lima; Rogério Rufino
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

9.  Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Michael Kreuter; Svenja Ehlers-Tenenbaum; Karin Palmowski; Jacques Bruhwyler; Ute Oltmanns; Thomas Muley; Claus Peter Heussel; Arne Warth; Martin Kolb; Felix J F Herth
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

10.  Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Chang Min Lee; Dong Ho Lee; Byung Kyu Ahn; Jae Jin Hwang; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  J Neurogastroenterol Motil       Date:  2016-07-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.